Joost J Oppenheim

Years Active: 2018-2020
Publications (10 Years): 5

NCI at Frederick

This page only lists publications with an associated author ORCID identifier.

Affiliation History

NCI at Frederick Jul 01 1962

United States

Principal Investigator :: LCIM

Publications

Tianzhen He, De Yang, Xiao-Qing Li, Mengmeng Jiang, Md Sahidul Islam, Shaokui Chen, Yibo Chen, Yang Yang, Chon-Kit Chou, Anna L Trivett, Joost J Oppenheim, Xin Chen
Inhibition of two-pore channels in antigen-presenting cells promotes the expansion of TNFR2-expressing CD4+Foxp3+ regulatory T cells. Science advances 6 (40) (2020)
Shuo Liu, Zhen Han, Anna L Trivett, Hongsheng Lin, Sean Hannifin, De Yang, Joost J Oppenheim
Cryptotanshinone has curative dual anti-proliferative and immunotherapeutic effects on mouse Lewis lung carcinoma. Cancer immunology, immunotherapy : CII 68 (7) (2019)
Zhen Han, Shuo Liu, Hongsheng Lin, Anna L Trivett, Sean Hannifin, De Yang, Joost J Oppenheim
Inhibition of murine hepatoma tumor growth by cryptotanshinone involves TLR7-dependent activation of macrophages and induction of adaptive antitumor immune defenses. Cancer immunology, immunotherapy : CII 68 (7) (2019)
Yingjie Nie, Jiang He, Hidekazu Shirota, Anna L Trivett, De Yang, Dennis M Klinman, Joost J Oppenheim, Xin Chen
Blockade of TNFR2 signaling enhances the immunotherapeutic effect of CpG ODN in a mouse model of colon cancer. Science signaling 11 (511) (2018)
De Yang, Zhen Han, Joost J Oppenheim
Alarmins and immunity. Immunological reviews 280 (1) (2018)

Joost J Oppenheim.css-eqlu8i{font-size:small;padding-left:4px;}